Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SAGE THERAPEUTICS, INC.

(SAGE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société SAGE THERAPEUTICS, INC.
06/16SAGE THERAPEUTICS  : and Biogen Announce Positive Pivotal Phase 3 Results for Zu..
AQ
06/15Cracker Barrel, Sage Therapeutics fall; Ocugen, FedEx rise
AQ
06/15SAGE THERAPEUTICS  : to Host Conference Call
BU
06/15SAGE THERAPEUTICS  : and Biogen Announce Positive Pivotal Phase 3 Results for Zu..
PU
06/15SAGE THERAPEUTICS, INC.  : Other Events, Financial Statements and Exhibits (form..
AQ
06/10SAGE THERAPEUTICS, INC.  : Submission of Matters to a Vote of Security Holders (..
AQ
05/20SAGE THERAPEUTICS  : Joins MTV Entertainment Group and More Than 1,300 Leading O..
BU
05/13SAGE THERAPEUTICS TO HOST SAGE SCIEN : SAGE-718 In Depth
BU
05/04SAGE THERAPEUTICS  : Company on-track to initiate placebo-controlled Phase 2 tri..
PU
05/04SAGE THERAPEUTICS  : Management's Discussion and Analysis of Financial Condition..
AQ
05/04SAGE THERAPEUTICS, INC.  : Results of Operations and Financial Condition, Financ..
AQ
05/04SAGE THERAPEUTICS  : Announces First Quarter 2021 Financial Results and Highligh..
BU
04/28SAGE THERAPEUTICS  : to Present at Upcoming May Investor Conferences
BU
04/20SAGE THERAPEUTICS  : to Report First Quarter 2021 Financial Results on Tuesday, ..
BU
04/12SAGE THERAPEUTICS, INC.  : Other Events, Financial Statements and Exhibits (form..
AQ
03/24SAGE THERAPEUTICS  : to Present at the Stifel 3rd Annual CNS Day
BU
03/18SAGE THERAPEUTICS, INC.  : Other Events, Financial Statements and Exhibits (form..
AQ
03/17SAGE THERAPEUTICS, INC.  : Change in Directors or Principal Officers (form 8-K)
AQ
03/17SAGE THERAPEUTICS  : Announces Continued Positive Zuranolone Data for Both 30 mg..
BU
03/16SAGE THERAPEUTICS  : Announces Departure of Chief Operating Officer
BU
02/24SAGE THERAPEUTICS  : Management's Discussion and Analysis of Financial Condition..
AQ
02/24SAGE THERAPEUTICS, INC.  : Results of Operations and Financial Condition, Financ..
AQ
02/24SAGE THERAPEUTICS  : Announces Fourth Quarter and Full Year 2020 Financial Resul..
BU
02/11SAGE THERAPEUTICS  : to Present at Upcoming Investor Conferences
BU
02/10SAGE THERAPEUTICS  : to Report Fourth Quarter and Full Year 2020 Financial Resul..
BU
01/07SAGE THERAPEUTICS, INC.  : Results of Operations and Financial Condition, Other ..
AQ
01/07SAGE THERAPEUTICS  : Provides 2021 Corporate Strategy Update at J.P. Morgan Heal..
BU
2020SAGE THERAPEUTICS, INC.  : Other Events (form 8-K)
AQ
2020SAGE THERAPEUTICS  : to Present at the 39th Annual J.P. Morgan Healthcare Confer..
BU
2020SAGE THERAPEUTICS, INC.  : Change in Directors or Principal Officers (form 8-K)
AQ
2020SAGE THERAPEUTICS  : Announces the Appointment of Barry Greene as CEO
BU
2020SAGE THERAPEUTICS  : to Present at BMO 2020 Growth and ESG Conference
AQ
2020SAGE THERAPEUTICS  : to Present at BMO 2020 Growth & ESG Conference
BU
2020BIOGEN  : and Sage Therapeutics Announce Global Collaboration to Develop and Com..
AQ
2020SAGE THERAPEUTICS, INC.  : Entry into a Material Definitive Agreement, Unregiste..
AQ
2020BIOGEN  : and Sage Therapeutics Announce Global Collaboration to Develop and Com..
AQ
2020SAGE THERAPEUTICS  : Management's Discussion and Analysis of Financial Condition..
AQ
2020SAGE THERAPEUTICS, INC.  : Results of Operations and Financial Condition, Financ..
AQ
2020SAGE THERAPEUTICS  : Announces Third Quarter 2020 Financial Results and Highligh..
BU
2020SAGE THERAPEUTICS  : to Present at Upcoming November Investor Conferences
AQ
2020SAGE THERAPEUTICS  : to Present at Upcoming November Investor Conferences
BU
2020SAGE THERAPEUTICS  : Announces Chief Executive Jeff Jonas to Undergo Scheduled M..
AQ
2020SAGE THERAPEUTICS  : Announces Chief Executive Jeff Jonas to Undergo Scheduled M..
BU
2020SAGE THERAPEUTICS  : to Report Third Quarter 2020 Financial Results on Thursday,..
AQ
2020SAGE THERAPEUTICS  : to Report Third Quarter 2020 Financial Results on Thursday,..
BU
2020SAGE THERAPEUTICS  : Announces Positive Interim, Topline Zuranolone Safety and T..
AQ
2020SAGE THERAPEUTICS, INC.  : Other Events, Financial Statements and Exhibits (form..
AQ
2020SAGE THERAPEUTICS  : Announces Positive Interim, Topline Zuranolone Safety and T..
BU
2020SAGE THERAPEUTICS  : Appoints Barry Greene to Board of Directors
AQ
2020SAGE THERAPEUTICS, INC.  : Change in Directors or Principal Officers, Other Even..
AQ
2020SAGE THERAPEUTICS  : Appoints Barry Greene to Board of Directors
BU
2020SAGE THERAPEUTICS  : rsquo; FutureCast to Provide Update on Pipeline Progression..
BU
2020SAGE THERAPEUTICS  : to Present at Morgan Stanley 18th Annual Global Healthcare ..
BU
2020SAGE THERAPEUTICS  : to Host Sage FutureCast Webcast
BU
2020SAGE THERAPEUTICS  : Management's Discussion and Analysis of Financial Condition..
AQ
2020SAGE THERAPEUTICS, INC.  : Results of Operations and Financial Condition, Financ..
AQ
2020SAGE THERAPEUTICS  : Announces Second Quarter 2020 Financial Results and Highlig..
BU
2020SAGE THERAPEUTICS  : to Present at 2020 Wedbush PacGrow Healthcare Virtual Confe..
BU
2020SAGE THERAPEUTICS  : to Report Second Quarter 2020 Financial Results on Monday, ..
BU
2020SAGE THERAPEUTICS, INC.  : Submission of Matters to a Vote of Security Holders (..
AQ
2020SAGE THERAPEUTICS  : to Present at Goldman Sachs 41st Annual Global Healthcare C..
BU
2020SAGE THERAPEUTICS  : to Present at Bank of America Health Care Conference 2020
AQ
2020SAGE THERAPEUTICS  : to Present at Bank of America Health Care Conference 2020
BU
2020SAGE THERAPEUTICS, INC.  : Results of Operations and Financial Condition, Change..
AQ
2020SAGE THERAPEUTICS  : Management's Discussion and Analysis of Financial Condition..
AQ
2020SAGE THERAPEUTICS  : Announces First Quarter 2020 Financial Results and Highligh..
BU
2020SAGE THERAPEUTICS  : to Report First Quarter 2020 Financial Results on Thursday,..
BU
2020SAGE THERAPEUTICS, INC.  : Costs Associated with Exit or Disposal Activities, Ot..
AQ
2020SAGE THERAPEUTICS  : Announces Restructuring to Advance Corporate Strategy and P..
BU
2020SAGE THERAPEUTICS  : Announces Inducement Grants Under NASDAQ Listing Rule 5635(..
AQ
2020SAGE THERAPEUTICS  : Announces Inducement Grants Under NASDAQ Listing Rule 5635(..
BU
2020SAGE THERAPEUTICS, INC.  : Other Events, Financial Statements and Exhibits (form..
AQ
2020SAGE THERAPEUTICS  : Announces Development Plan for Zuranolone (SAGE-217) Follow..
BU
2020SAGE THERAPEUTICS  : Announces Inducement Grants Under NASDAQ Listing Rule 5635(..
BU
2020SAGE THERAPEUTICS  : SEC Filing (S-8)
PU
1  2  3  4  5Next
Upcoming event on SAGE THERAPEUTICS, INC.